Company Overview of bioCSL Inc.
bioCSL Inc. manufactures and supplies flu vaccines. The company offers AFLURIA, an inactivated influenza vaccine indicated for active immunization against influenza disease caused by influenza virus subtypes A and type B present in the vaccine. It provides flu vaccine to Australia, New Zealand, and various countries in Europe, South America, and Asia. The company’s products are available through a network of distributors. bioCSL Inc. was formerly known as CSL Biotherapies, Inc. and changed its name to bioCSL Inc. The company was founded in 1968 and is based in King of Prussia, Pennsylvania. bioCSL Inc. operates as a subsidiary of CSL Ltd.
1020 First Avenue
King of Prussia, PA 19406
Founded in 1968
Key Executives for bioCSL Inc.
bioCSL Inc. Key Developments
Similar Private Companies By Industry
|Kalypsys, Inc.||United States|
|Applied Therapeutics, Inc.||United States|
|Vaccinex, Inc.||United States|
|Eagle Vision Pharmaceutical Corporation||United States|
|Third Stream Bioscience, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- New York City, NY | InformaticaPosted: Feb 20
- Santa Monica, CA | AstellasPosted: Mar 10
- Princeton, NJ | RGPPosted: Mar 05
- San Francisco, CA | PwCPosted: Apr 12
Sponsored Financial Commentaries
To contact bioCSL Inc., please visit www.cslbiotherapies-us.com. Company data is provided by Capital IQ. Please use this form to report any data issues.